2021
Non-pharmacological treatments (NPTs) have the potential to improve meaningful outcomes for older people at risk of, or living with dementia, (…)
Consulter 
2021
Ischemic stroke is a leading cause of disability, with its treatment not yet optimal. It is thus mandatory to make (…)
Consulter
2021
In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received (…)
Consulter
2021
We classified non-demented European Prevention of Alzheimer’s Dementia (EPAD) participants through the amyloid/tau/neurodegeneration (ATN) scheme and assessed their neuropsychological and (…)
Consulter
2021
Consulter
2021
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. AD is a genetic (…)
Consulter
